Kiniksa Pharmaceuticals Launches TV Campaign for ARCALYST® in Recurrent Pericarditis

Kiniksa Pharmaceuticals has initiated a targeted direct-to-consumer TV campaign for its drug ARCALYST® (rilonacept), specifically for the treatment of recurrent pericarditis. The campaign aims to raise awareness and inform patients about the medication.